Compare SPDR Gold Trust (GLD) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Halozyme Therapeutics Inc. Common Stock — how do they compare? SPDR Gold Trust trades at $384.58 (market cap $139.66B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: SPDR Gold Trust is far larger — about 11.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GLD | HALO | |
|---|---|---|
Market Cap | $139.66B | $12.58B |
Volume | 9,544,773 | 2,179,278 |
52-Week High | $495.90 | $115.22 |
52-Week Low | $362.32 | $61.63 |
Typical Hold Time | 74 Days | 1 Days |
Sector | — | Health |
Enterprise Value | — | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD trades at $384.58, up 2.31% with bearish technical signals dominating. The ETF faces pressure from rising Treasury yields and a strong dollar, with technical indicators showing 17 sell signals versus 2 buy signals. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels amid Federal Reserve policy uncertainty.
The outlook remains cautious as elevated yields and dollar strength create headwinds, though some analysts see tactical opportunities near current levels. Key risks include further Fed tightening and bond market volatility, while potential catalysts include geopolitical tensions and inflation concerns. The technical setup suggests continued pressure with support at $377-$374.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
